(CCEP) Coca-Cola European Partners - Ratings and Ratios
Soft Drinks, Water, Juice, Energy, Coffee
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.9% |
| Value at Risk 5%th | 30.4% |
| Relative Tail Risk | -2.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 13.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.422 |
| Beta | 0.221 |
| Beta Downside | 0.436 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.35% |
| Mean DD | 3.75% |
| Median DD | 2.93% |
Description: CCEP Coca-Cola European Partners September 29, 2025
Coca-Cola Europacific Partners PLC (NASDAQ: CCEP) is a bottling and distribution business that manufactures, markets, and sells a broad suite of non-alcoholic ready-to-drink beverages across Europe and the Pacific region.
The company’s portfolio spans carbonated soft drinks (Coca-Cola Original Taste, Zero Sugar, Diet Coke, Sprite, Fanta, etc.), low-calorie and zero-sugar variants, water and enhanced-water brands (Bonaqua, smartwater, Aquarius), energy drinks (Monster, Burn, Reign), teas and coffees (Fuze Tea, Barista Bros, Giancarlo Coffee), juices, isotonic sports drinks, and a selection of licensed alcoholic-ready-to-drink products (e.g., BACARDÍ RTD, Jack Daniel’s RTD). This extensive brand list is sold under the Coca-Cola system franchise.
The firm was originally incorporated as Coca-Cola European Partners plc and rebranded to Coca-Cola Europacific Partners plc in May 2021. It traces its heritage to 1904 and is headquartered in Uxbridge, United Kingdom.
Key operational metrics (FY 2023) include revenue of approximately $13.3 billion, an adjusted EBITDA margin of roughly 15 % and net debt of about $7 billion, reflecting the capital-intensive nature of bottling assets. Primary economic drivers are commodity price volatility (sugar, aluminum, PET resin), foreign-exchange exposure across the euro, pound and Pacific currencies, and shifting consumer preferences toward healthier, low-calorie and premium RTD formats, which have been boosting volume growth in water and energy-drink categories.
For a deeper, data-driven view of CCEP’s valuation sensitivities, the ValueRay platform provides a transparent model you can explore at your own pace.
CCEP Stock Overview
| Market Cap in USD | 42,233m |
| Sub-Industry | Soft Drinks & Non-alcoholic Beverages |
| IPO / Inception | 1987-01-01 |
| Return 12m vs S&P 500 | 7.26% |
| Analyst Rating | 4.0 of 5 |
CCEP Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.59% |
| Yield on Cost 5y | 6.26% |
| Yield CAGR 5y | 20.81% |
| Payout Consistency | 94.1% |
| Payout Ratio | 109.0% |
CCEP Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 23.84% |
| CAGR/Max DD Calmar Ratio | 1.66 |
| CAGR/Mean DD Pain Ratio | 6.35 |
| Current Volume | 1588.1k |
| Average Volume | 1432.1k |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (3.15b TTM) > 0 and > 6% of Revenue (6% = 2.40b TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 8.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.02% (prev -4.84%; Δ 0.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 5.55b > Net Income 3.15b (YES >=105%, WARN >=100%) |
| Net Debt (10.35b) to EBITDA (6.43b) ratio: 1.61 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (459.0m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 35.88% (prev 36.21%; Δ -0.33pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 130.0% (prev 90.70%; Δ 39.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.13 (EBITDA TTM 6.43b / Interest Expense TTM 438.4m) >= 6 (WARN >= 3) |
Altman Z'' 2.00
| (A) -0.05 = (Total Current Assets 8.08b - Total Current Liabilities 9.69b) / Total Assets 31.79b |
| (B) 0.28 = Retained Earnings (Balance) 8.95b / Total Assets 31.79b |
| (C) 0.16 = EBIT TTM 4.88b / Avg Total Assets 30.79b |
| (D) 0.33 = Book Value of Equity 7.72b / Total Liabilities 23.28b |
| Total Rating: 2.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.66
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 8.64% = 4.32 |
| 3. FCF Margin 10.00% = 2.50 |
| 4. Debt/Equity 1.50 = 1.47 |
| 5. Debt/Ebitda 1.61 = 0.76 |
| 6. ROIC - WACC (= 13.55)% = 12.50 |
| 7. RoE 38.11% = 2.50 |
| 8. Rev. Trend 67.08% = 5.03 |
| 9. EPS Trend -18.52% = -0.93 |
What is the price of CCEP shares?
Over the past week, the price has changed by -1.58%, over one month by +1.00%, over three months by +2.12% and over the past year by +21.84%.
Is CCEP a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the CCEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95.9 | 6.3% |
| Analysts Target Price | 95.9 | 6.3% |
| ValueRay Target Price | 111.6 | 23.7% |
CCEP Fundamental Data Overview November 15, 2025
P/E Trailing = 23.6822
P/E Forward = 18.4502
P/S = 2.0223
P/B = 4.5299
P/EG = 1.5254
Beta = 0.383
Revenue TTM = 40.04b EUR
EBIT TTM = 4.88b EUR
EBITDA TTM = 6.43b EUR
Long Term Debt = 9.22b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.26b EUR (from shortTermDebt, last quarter)
Debt = 12.01b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.35b EUR (from netDebt column, last quarter)
Enterprise Value = 46.34b EUR (36.38b + Debt 12.01b - CCE 2.06b)
Interest Coverage Ratio = 11.13 (Ebit TTM 4.88b / Interest Expense TTM 438.4m)
FCF Yield = 8.64% (FCF TTM 4.00b / Enterprise Value 46.34b)
FCF Margin = 10.00% (FCF TTM 4.00b / Revenue TTM 40.04b)
Net Margin = 7.86% (Net Income TTM 3.15b / Revenue TTM 40.04b)
Gross Margin = 35.88% ((Revenue TTM 40.04b - Cost of Revenue TTM 25.67b) / Revenue TTM)
Gross Margin QoQ = 35.34% (prev 35.58%)
Tobins Q-Ratio = 1.46 (Enterprise Value 46.34b / Total Assets 31.79b)
Interest Expense / Debt = 0.82% (Interest Expense 98.0m / Debt 12.01b)
Taxrate = 25.63% (323.0m / 1.26b)
NOPAT = 3.63b (EBIT 4.88b * (1 - 25.63%))
Current Ratio = 0.83 (Total Current Assets 8.08b / Total Current Liabilities 9.69b)
Debt / Equity = 1.50 (Debt 12.01b / totalStockholderEquity, last quarter 8.03b)
Debt / EBITDA = 1.61 (Net Debt 10.35b / EBITDA 6.43b)
Debt / FCF = 2.59 (Net Debt 10.35b / FCF TTM 4.00b)
Total Stockholder Equity = 8.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.90% (Net Income 3.15b / Total Assets 31.79b)
RoE = 38.11% (Net Income TTM 3.15b / Total Stockholder Equity 8.25b)
RoCE = 27.93% (EBIT 4.88b / Capital Employed (Equity 8.25b + L.T.Debt 9.22b))
RoIC = 18.83% (NOPAT 3.63b / Invested Capital 19.27b)
WACC = 5.29% (E(36.38b)/V(48.40b) * Re(6.83%) + D(12.01b)/V(48.40b) * Rd(0.82%) * (1-Tc(0.26)))
Discount Rate = 6.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.11%
[DCF Debug] Terminal Value 77.02% ; FCFE base≈2.90b ; Y1≈2.67b ; Y5≈2.40b
Fair Price DCF = 95.99 (DCF Value 43.23b / Shares Outstanding 450.4m; 5y FCF grow -9.98% → 3.0% )
EPS Correlation: -18.52 | EPS CAGR: -53.60% | SUE: 0.0 | # QB: 0
Revenue Correlation: 67.08 | Revenue CAGR: 41.93% | SUE: 2.21 | # QB: 1
Additional Sources for CCEP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle